A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period
A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period
The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.
This trial in adult participants ≥ 18 years with non-segmental vitiligo (NSV) consists of a randomized, double-blind, placebo-controlled period to establish and characterize the dose-response relationship of GIA632 and estimate the targeted doses treatment effect compared with placebo, followed by the assessment of longer term safety and efficacy in extension period.
Inclusion Criteria:
Exclusion Criteria:
novartis.email@novartis.com1-888-669-6682
+41613241111
Birmingham, Alabama 35244, United States
wbooth@cahabaderm.com+1 205 778 1564
Fort Gratiot, Michigan 48059, United States
lcampbell@hamzavi.com+1 810 455 1600
Caba, Buenos Aires C1119ACN, Argentina
kespinoza@dermcaremgt.com+1 714 531 2966
kcadag@medderm.net+1 619 243 7015
clinicaltrials@calderm.net+1 888 367 1850
yhall@encoremedicalresearch.com+1 954 400 1725
hughes.jarell@mayo.edu+1 904 953 2000
swaneec@miamidermlaser.com+1 305 279 6060
mperez@researchgcp.com+1 727 520 1427
mgaidzik@ecommunity.com+1 317 516 5030#102
mpara@rev-research.com+1 248 564 1485
Schyler@LovelySkin.com+1 402 334 7546
ftrujillo@lvderm.com+1 702 456 3120
lcabreja@equity-med.com
mlamey@oregonmedicalresearch.com+1 503 245 0315
mguy@icresearch.net+1 615 410 3450
luis.leal@bellairedermatology.com+1 832 553 2308
privas@ccstexas.com+1 713 528 8818
tolga.han@atxresearch.com+1 512 259 2545
JaniT@acrctrials.com+1 972 354 1520
ctemple@vcrinc.org+1 757 625 0151